Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy

Title
Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy
Authors
Keywords
-
Journal
JAMA Oncology
Volume 2, Issue 1, Pages 118
Publisher
American Medical Association (AMA)
Online
2015-10-16
DOI
10.1001/jamaoncol.2015.3934

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search